Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Witold Ruzyllo

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
European Heart Journal|March 17, 2005
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologySigmund Silber, Per Albertsson, Francisco F Avilés, et al.
American Heart Journal|September 29, 2009
Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct arteryJason N Katz, Amanda L Stebbins, John H Alexander, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 11, 2010
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)Helen C Routledge, Thierry Lefèvre, Antonio Colombo, et al.
Circulation|February 2, 2006
Gender differences in the management and clinical outcome of stable anginaCaroline Daly, Felicity Clemens, Jose L Lopez Sendon, et al.
European Heart Journal|May 18, 2006
The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable anginaCaroline Daly, Felicity Clemens, Jose L Lopez-Sendon, et al.
Circulation|August 20, 2003
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trialKenneth W Mahaffey, Christopher B Granger, Jose C Nicolau, et al.
European Heart Journal|May 29, 2008
Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physiciansWillem J Remme, John J V McMurray, F D Richard Hobbs, et al.
Journal of the American College of Cardiology|June 15, 2004
A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) StudyMaarten L Simoons, Inge W G Bobbink, Jean Boland, et al.
European Heart Journal|February 18, 2005
The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable AnginaCaroline A Daly, Felicity Clemens, Jose L Lopez Sendon, et al.
The New England Journal of Medicine|March 28, 2007
Effect of torcetrapib on the progression of coronary atherosclerosisSteven E Nissen, Jean-Claude Tardif, Stephen J Nicholls, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
European Heart Journal|March 17, 2005
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologySigmund Silber, Per Albertsson, Francisco F Avilés, et al.
American Heart Journal|September 29, 2009
Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct arteryJason N Katz, Amanda L Stebbins, John H Alexander, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 11, 2010
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)Helen C Routledge, Thierry Lefèvre, Antonio Colombo, et al.
Circulation|February 2, 2006
Gender differences in the management and clinical outcome of stable anginaCaroline Daly, Felicity Clemens, Jose L Lopez Sendon, et al.
European Heart Journal|May 18, 2006
The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable anginaCaroline Daly, Felicity Clemens, Jose L Lopez-Sendon, et al.
Circulation|August 20, 2003
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trialKenneth W Mahaffey, Christopher B Granger, Jose C Nicolau, et al.
European Heart Journal|May 29, 2008
Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physiciansWillem J Remme, John J V McMurray, F D Richard Hobbs, et al.
Journal of the American College of Cardiology|June 15, 2004
A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) StudyMaarten L Simoons, Inge W G Bobbink, Jean Boland, et al.
European Heart Journal|February 18, 2005
The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable AnginaCaroline A Daly, Felicity Clemens, Jose L Lopez Sendon, et al.
The New England Journal of Medicine|March 28, 2007
Effect of torcetrapib on the progression of coronary atherosclerosisSteven E Nissen, Jean-Claude Tardif, Stephen J Nicholls, et al.
Pageof 11